These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 12771603

  • 1. Lipoprotein metabolism in patients with severe sepsis.
    van Leeuwen HJ, Heezius EC, Dallinga GM, van Strijp JA, Verhoef J, van Kessel KP.
    Crit Care Med; 2003 May; 31(5):1359-66. PubMed ID: 12771603
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in HDL-associated apolipoproteins relate to mortality in human sepsis and correlate to monocyte and platelet activation.
    Barlage S, Gnewuch C, Liebisch G, Wolf Z, Audebert FX, Glück T, Fröhlich D, Krämer BK, Rothe G, Schmitz G.
    Intensive Care Med; 2009 Nov; 35(11):1877-85. PubMed ID: 19669126
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of pravastatin, an HMG CoA reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by their apolipoprotein composition.
    Bard JM, Parra HJ, Douste-Blazy P, Fruchart JC.
    Metabolism; 1990 Mar; 39(3):269-73. PubMed ID: 2106607
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC, Brown LE, Stone PH, Silverman DI, Gibson CM, Sacks FM.
    Ann Intern Med; 1996 Oct 01; 125(7):529-40. PubMed ID: 8815751
    [Abstract] [Full Text] [Related]

  • 10. The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls.
    Parish S, Peto R, Palmer A, Clarke R, Lewington S, Offer A, Whitlock G, Clark S, Youngman L, Sleight P, Collins R, International Studies of Infarct Survival Collaborators.
    Eur Heart J; 2009 Sep 01; 30(17):2137-46. PubMed ID: 19520708
    [Abstract] [Full Text] [Related]

  • 11. Comparative effects of 10-mg versus 80-mg Atorvastatin on high-sensitivity C-reactive protein in patients with stable coronary artery disease: results of the CAP (Comparative Atorvastatin Pleiotropic effects) study.
    Bonnet J, McPherson R, Tedgui A, Simoneau D, Nozza A, Martineau P, Davignon J, CAP Investigators.
    Clin Ther; 2008 Dec 01; 30(12):2298-313. PubMed ID: 19167589
    [Abstract] [Full Text] [Related]

  • 12. A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial.
    Soran H, Liu Y, Adam S, Siahmansur T, Ho JH, Schofield JD, Kwok S, Gittins M, France M, Younis N, Gibson JM, Durrington PN, Rutter MK.
    J Clin Lipidol; 2018 Dec 01; 12(1):44-55. PubMed ID: 29246729
    [Abstract] [Full Text] [Related]

  • 13. Association between paraoxonase-1 activity and lipid peroxidation indicator levels in people living in the Antalya region with angiographically documented coronary artery disease.
    Göçmen AY, Gümüşlü S, Semiz E.
    Clin Cardiol; 2004 Jul 01; 27(7):426-30. PubMed ID: 15298047
    [Abstract] [Full Text] [Related]

  • 14. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R, Liu Y, Kwok S, Hama S, France M, Eatough R, Pemberton P, Schofield J, Siahmansur TJ, Malik R, Ammori BA, Issa B, Younis N, Donn R, Stevens A, Durrington P, Soran H.
    J Am Heart Assoc; 2015 Sep 15; 4(9):e001508. PubMed ID: 26374297
    [Abstract] [Full Text] [Related]

  • 15. Variation in plasma lipid and lipoprotein concentrations in community-acquired pneumonia a six-month prospective study.
    Rodriguez Reguero JJ, Iglesias Cubero G, Vazquez M, Folgueras I, Braga S, Bustillo E, Mosquera JA.
    Eur J Clin Chem Clin Biochem; 1996 Mar 15; 34(3):245-9. PubMed ID: 8721412
    [Abstract] [Full Text] [Related]

  • 16. Low serum level of high-density lipoprotein cholesterol is a poor prognostic factor for severe sepsis.
    Chien JY, Jerng JS, Yu CJ, Yang PC.
    Crit Care Med; 2005 Aug 15; 33(8):1688-93. PubMed ID: 16096442
    [Abstract] [Full Text] [Related]

  • 17. Overall and Sex-Specific Effect of Berberine for the Treatment of Dyslipidemia in Adults: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.
    Blais JE, Huang X, Zhao JV.
    Drugs; 2023 Apr 15; 83(5):403-427. PubMed ID: 36941490
    [Abstract] [Full Text] [Related]

  • 18. L-Carnitine supplementation reduces oxidized LDL cholesterol in patients with diabetes.
    Malaguarnera M, Vacante M, Avitabile T, Malaguarnera M, Cammalleri L, Motta M.
    Am J Clin Nutr; 2009 Jan 15; 89(1):71-6. PubMed ID: 19056606
    [Abstract] [Full Text] [Related]

  • 19. Correlates of serum lipids and lipoproteins in Congolese patients with arterial hypertension.
    Lepira FB, M'Buyamba-Kabangu JR, Kayembe KP, Nseka MN.
    Cardiovasc J S Afr; 2005 Jan 15; 16(5):249-55. PubMed ID: 16307156
    [Abstract] [Full Text] [Related]

  • 20. [Assessment of metabolic atherosclerosis risk factors in progeny of patients with past ischemic stroke].
    Mierzecki A, Bukowska H, Honczarenko K, Jastrzebska M, Millo B, Torbus-Lisiecka B.
    Pol Arch Med Wewn; 2005 Feb 15; 113(2):119-29. PubMed ID: 16209232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.